Skip to main content

Table 4 Initial contact detection (ICD) performance measures. Sensitivity, positive predictive value, absolute and relative errors, and overall performance index for the ICD algorithms. Values are expressed as mean and 95% confidence intervals (CI) for each cohort. In italic face: recommended algorithms. Underlined performance index indicates top-ranked algorithm for the specific cohort of that row

From: Assessing real-world gait with digital technology? Validation, insights and recommendations from the Mobilise-D consortium

Cohort

Initial contact detection

Sensitivity

Positive predictive value

Absolute error [s]

Relative error [%]

Performance index

ICDA

 HA

0.80 [0.79, 0.81]

0.91 [0.90, 0.92]

0.06 [0.05, 0.06]

8.0 [7.7, 8.3]

0.804

 CHF

0.79 [0.77, 0.80]

0.89 [0.88, 0.91]

0.07 [0.06, 0.07]

10.9 [10.1, 11.8]

0.771

 COPD

0.81 [0.81, 0.82]

0.93 [0.92, 0.94]

0.07 [0.06, 0.07]

9.1 [8.8, 9.3]

0.790

 MS

0.80 [0.79, 0.82]

0.92 [0.91, 0.93]

0.06 [0.06, 0.06]

8.4 [8.1, 8.7]

0.805

 PD

0.79 [0.77, 0.80]

0.90 [0.89, 0.91]

0.06 [0.06, 0.06]

8.3 [7.9, 8.6]

0.798

 PFF

0.80 [0.78, 0.81]

0.89 [0.88, 0.90]

0.05 [0.05, 0.06]

7.6 [7.3, 7.9]

0.818

ICDB

 HA

0.80 [0.79, 0.81]

0.86 [0.85, 0.87]

0.13 [0.13, 0.13]

18.0 [17.8, 18.3]

0.641

 CHF

0.80 [0.78, 0.81]

0.88 [0.86, 0.90]

0.13 [0.13, 0.14]

19.9 [19.3, 20.4]

0.641

 COPD

0.78 [0.77, 0.79]

0.85 [0.84, 0.86]

0.15 [0.15, 0.15]

21.2 [20.9, 21.5]

0.590

 MS

0.75 [0.73, 0.77]

0.81 [0.79, 0.83]

0.14 [0.14, 0.15]

19.8 [19.3, 20.4]

0.595

 PD

0.80 [0.78, 0.81]

0.86 [0.84, 0.88]

0.14 [0.14, 0.14]

19.2 [18.9, 19.6]

0.620

 PFF

0.80 [0.79, 0.82]

0.86 [0.85, 0.88]

0.13 [0.13, 0.13]

17.9 [17.5, 18.2]

0.641

ICDC

 HA

0.82 [0.81, 0.83]

0.86 [0.85, 0.88]

0.06 [0.06, 0.07]

8.9 [8.6, 9.2]

0.795

 CHF

0.81 [0.80, 0.82]

0.87 [0.85, 0.88]

0.07 [0.07, 0.08]

11.1 [10.2, 11.9]

0.771

 COPD

0.83 [0.82, 0.83]

0.90 [0.89, 0.91]

0.07 [0.07, 0.07]

9.7 [9.4, 9.9]

0.786

 MS

0.82 [0.81, 0.84]

0.89 [0.87, 0.90]

0.07 [0.06, 0.07]

9.2 [8.8, 9.6]

0.783

 PD

0.80 [0.78, 0.81]

0.84 [0.82, 0.86]

0.07 [0.07, 0.07]

9.4 [9.0, 9.8]

0.766

 PFF

0.80 [0.79, 0.82]

0.81 [0.79, 0.82]

0.07 [0.07, 0.07]

9.6 [9.2, 10.0]

0.759

ICDD

 HA

0.78 [0.77, 0.79]

0.88 [0.87, 0.89]

0.10 [0.10, 0.10]

14.1 [13.8, 14.5]

0.705

 CHF

0.79 [0.78, 0.81]

0.92 [0.91, 0.93]

0.09 [0.09, 0.10]

13.8 [13.4, 14.3]

0.735

 COPD

0.76 [0.75, 0.77]

0.89 [0.88, 0.90]

0.11 [0.11, 0.12]

15.9 [15.5, 16.3]

0.680

 MS

0.78 [0.77, 0.80]

0.89 [0.88, 0.91]

0.10 [0.10, 0.11]

14.4 [13.9, 15.0]

0.706

 PD

0.76 [0.75, 0.78]

0.86 [0.84, 0.87]

0.11 [0.11, 0.11]

15.4 [15.0, 15.8]

0.674

 PFF

0.80 [0.78, 0.81]

0.86 [0.85, 0.88]

0.10 [0.09, 0.10]

13.6 [13.1, 14.1]

0.706

  1. HA healthy adults; PD Parkinson’s disease; MS multiple sclerosis; COPD chronic obstructive pulmonary disease; CHF congestive heart failure; PFF proximal femoral fracture; LoA limits of agreement